| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
C4 Therapeutics, Inc. (CCCC) has 5 insiders with recent SEC Form 4 filings, including 2 buys and 11 sells. CCCC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 165.1K | $685.2K | - | |
| Other | 156.4K | $649.0K | - | |
| Dir | 146.5K | $608.1K | - | |
| Other | 105.0K | $435.8K | - | |
| Dir | 66.1K | $274.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 2, 2021 | Fisher Stewart63 | Chief Scientific Officer | Sell | 68,315 | $45.00 | $3,074,386.61 | -41.1% | +2.6% | -77.6% | |
| Jul 29, 2021 | Siegel Jolie | Chief Legal Officer | Sale+OE | 12,500 | $45.00 | $562,500.00 | -100% | +3.2% | -77.9% | |
| Jul 29, 2021 | Crystal Adam78 | Chief Medical Officer | Sale+OE | 15,000 | $45.00 | $675,000.00 | -100% | +3.2% | -77.9% | |
| Jul 16, 2021 | Salter Malcolm83 | Director | Sell | 755 | $37.37 | $28,214.35 | -5.0% | +10.7% | -74.9% | |
| Jul 1, 2021 | Crystal Adam78 | Chief Medical Officer | Sale+OE | 15,000 | $37.98 | $569,665.79 | -89.8% | +23.6% | -79.3% | |
| Jun 18, 2021 | Salter Malcolm83 | Director | Sell | 755 | $37.19 | $28,078.45 | -4.8% | +30.6% | -85.8% | |
| May 21, 2021 | Salter Malcolm83 | Director | Sell | 755 | $37.12 | $28,025.60 | -4.6% | +12.2% | -81.7% | |
| Apr 5, 2021 | Crystal Adam78 | Chief Medical Officer | Sale+OE | 15,000 | $37.77 | $566,535.97 | -58.0% | +4.0% | -41.3% | |
| Oct 6, 2020 | McKee William | Chief Financial Officer | Buy | 5,263 | $19.00 | $99,997.00 | New | - | - | |
| Oct 6, 2020 | Cohen Marc A | Director, 10% Owner | Buy | 5,030 | $19.00 | $95,570.00 | New | - | - |